1. ALLA AKTIER
  2. NYHETER
  3. CHORDATE MEDICAL

Chordate Medical

Nyheter Chordate Medical Nyheter alla bolag

Chordate Medical's joint venture submits application for product registration in China

MARKN.

Chordate Medical and Nanos Medical's joint venture Changyong Medical Technology Co. has submitted an application for product registration for the K.O.S treatment for chronic rhinitis in China.

“This is an important step towards market access in China. The next step in the project is entirely dependent on the answers we get from the Chinese supervisory authority's review work”, says Anders Weilandt, CEO of Chordate.

Chordate and Nanos Medical started a joint venture in 2018, forming the jointly owned company Changyong Medical Technology Co in Shanghai with the intention of marketing the K.O.S technology in the Chinese market. Nanos Medical owns two-thirds of this company and is the party that finances marketing and sales. Chordate owns the remaining third and will supply the Chinese patents when market authorization and product registration are in place.

For more information, please contact:
Anders Weilandt, CEO
anders.weilandt@chordate.com
Cell: +46 733-874277

About Chordate
Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (K.O.S). The K.O.S-treatment has clinically proven efficacy according to scientific studies. The company's products are available via distributors to clinics in the Nordic countries, Germany, the UK, Italy, Israel, and Saudi Arabia. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at www.chordate.com

The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Västra Hamnen Corporate Finance AB.

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.

Attachments
Chordate Medical's joint venture submits application for product registration in China

Datum 2023-02-21, kl 13:30
Källa MFN
Bifogade filer
Chordate Medical's joint venture submits application for product registration in China
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!